Your browser doesn't support javascript.
loading
Genetic Variants in Double-Strand Break Repair Pathway Genes to Predict Platinum-Based Chemotherapy Prognosis in Patients With Lung Cancer.
Liu, Jun-Yan; Zou, Ting; Yin, Ji-Ye; Wang, Zhan; Liu, Chong; Huang, Han-Xue; Ding, Fei-Xiang; Lei, Meng-Rong; Wang, Ying; Liu, Min; Liu, Zhao-Qian; Tan, Li-Ming; Chen, Juan.
Afiliação
  • Liu JY; Department of Orthopaedics, Xiangya Hospital, Central South University, Changsha, China.
  • Zou T; National Institution of Drug Clinical Trial, Xiangya Hospital, Central South University, Changsha, China.
  • Yin JY; Departments of Clinical Pharmacology, Xinagya Hospital, Central South University, Changsha, China.
  • Wang Z; Institute of Clinical Pharmacology and Hunan Key Laboratory of Pharmacogenetics, Central South University, Changsha, China.
  • Liu C; Lung Cancer and Gastrointestinal Unit, Department of Medical Oncology, Hunan Cancer Hospital, Affiliated Cancer Hospital of Xiangya School of Medicine, Changsha, China.
  • Huang HX; Institute of Clinical Pharmacology and Hunan Key Laboratory of Pharmacogenetics, Central South University, Changsha, China.
  • Ding FX; Institute of Clinical Pharmacology and Hunan Key Laboratory of Pharmacogenetics, Central South University, Changsha, China.
  • Lei MR; Institute of Clinical Pharmacology and Hunan Key Laboratory of Pharmacogenetics, Central South University, Changsha, China.
  • Wang Y; Institute of Clinical Pharmacology and Hunan Key Laboratory of Pharmacogenetics, Central South University, Changsha, China.
  • Liu M; Hunan Clinical Research Center in Gynecologic Cancer, Hunan Cancer Hospital, Affiliated Cancer Hospital of Xiangya School of Medicine, Changsha, China.
  • Liu ZQ; Xiangya School of Pharmaceutical Sciences, Central South University, Changsha, China.
  • Tan LM; National Institution of Drug Clinical Trial, Xiangya Hospital, Central South University, Changsha, China.
  • Chen J; Departments of Clinical Pharmacology, Xinagya Hospital, Central South University, Changsha, China.
Front Pharmacol ; 13: 915822, 2022.
Article em En | MEDLINE | ID: mdl-35899106

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Ano de publicação: 2022 Tipo de documento: Article